Hyperlipidaemia in diabetes (Q37786744)

23 August 2017

1 reference

title

Hyperlipidaemia in diabetes (English)

1 reference

23 August 2017

1 reference

Taskinen MR

1

1 reference

23 August 2017

publication date

1 December 1990

1 reference

Bailliere's clinical endocrinology and metabolism

23 August 2017

published in

1 reference

23 August 2017

volume

4

1 reference

23 August 2017

issue

4

1 reference

23 August 2017

page(s)

743-775

1 reference

Nutritional recommendations and principles for individuals with diabetes mellitus: 1986. American Diabetes Association

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Improved diabetic control and hypocholesterolaemic effect induced by long-term dietary supplementation with guar gum in type 2 (insulin-independent) diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma lipids and diabetes mellitus in an adult community

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

The Correlation of Arteriosclerosis Obliterans with Lipoproteins in Insulin-Dependent and Non-Insulin-Dependent Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipoprotein subfraction composition in non-insulin-dependent diabetes treated by diet, sulphonylurea, and insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipids, lipoproteins and apolipoproteins in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Chylomicronemia syndrome in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Alterations in serum lipids and apolipoproteins in male type 1 (insulin-dependent) diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effects of insulin and glucose on very low density lipoprotein triglyceride secretion by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Management of dyslipidemia in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Relationship between lipoprotein levels and in vivo insulin action in normal young white men.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Hyperlipidaemia of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma levels of apoprotein B in patients with diabetes mellitus: the effect of glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Fibric acids: effects on lipids and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

High density lipoprotein subfractions during continuous insulin infusion therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effect of variation in diet on lipoprotein metabolism in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lowering of plasma glucose concentrations with bezafibrate in patients with moderately controlled NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Significance of hepatic triglyceride lipase activity in the regulation of serum high density lipoproteins in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Interaction of very-low-density lipoprotein isolated from type I (insulin-dependent) diabetic subjects with human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Improvement of glucose tolerance in NIDDM by clofibrate. Randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Decreased plasma phosphatidylcholine/free cholesterol ratio as an indicator of risk for ischemic vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Adverse effects of obesity on lipid and lipoprotein levels in insulin-dependent and non-insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Heterogeneity of apolipoprotein A-I turnover in subjects with reduced concentrations of plasma high density lipoprotein cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effect of Metabolic Control on Lipid, Lipoprotein, and Apolipoprotein Levels in 55 Insulin-dependent Diabetic Patients: A Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Glycosylation of low density lipoprotein in patients with type 1 (insulin-dependent) diabetes: correlations with other parameters of glycaemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

High density lipoprotein subfractions in insulin-dependent diabetic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

THE EFFECT OF NICOTINIC ACID IN DIABETES MELLITUS

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Serum Lipids and Lipoproteins in Insulin-treated Diabetes: Demonstration of Increased High Density Lipoprotein Concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Plasma triglyceride transport kinetics in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Quantitative relationship between plasma lipids and glycohemoglobin in type I patients. Longitudinal study of 212 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Human splanchnic metabolism during diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Role of insulin in lipoprotein secretion by cultured rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

The effect of continuous subcutaneous insulin infusion on very-low-density lipoprotein triglyceride metabolism in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Abnormal lipoprotein metabolism in non-insulin-dependent diabetes mellitus. Pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effects of bezafibrate on insulin secretion and peripheral insulin sensitivity in hyperlipidemic patients with and without diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Presence of very low density lipoprotein compositional abnormalities in Type 1 (insulin-dependent) diabetic patients; effects of blood glucose optimisation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Serum lipids, lipoproteins, and apolipoproteins and the excessive occurrence of coronary heart disease in non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Reduction in cardiovascular risk factors with intensive diabetes treatment in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Improvement in diabetes control by treatment with bezafibrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Association of serum lipids and lipoproteins with plasma C-peptide concentration in non-insulin-dependent diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Apolipoproteins (A-I, A-II, B), Lp(a) lipoprotein and lecithin: Cholesterol acyltransferase activity in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Triglyceride-rich lipoprotein metabolism during acute hyperinsulinemia in hypertriglyceridemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Insulin effects on apolipoprotein B lipoprotein synthesis and secretion by primary cultures of rat hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lack of Awareness and Treatment of Hyperlipidemia in Type II Diabetes in a Community Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Apolipoproteins and lipoproteins in children with type I diabetes: relation to glycosylated serum protein and HbA1

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Enzymes involved in triglyceride hydrolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipoprotein lipase activity of adipose tissue and skeletal muscle in insulin-deficient human diabetes. Relation to high-density and very-low-density lipoproteins and response to treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipoprotein lipase activity and serum lipoproteins in untreated type 2 (insulin-independent) diabetes associated with obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Overview of clinical trials of cholesterol lowering in relationship to epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesterol and triglyceride levels

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipid abnormalities in insulin-dependent diabetic patients with albuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Type 1 (insulin-dependent) versus type 2 (non-insulin-dependent) diabetes mellitus: characterization of serum lipoprotein alterations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Lipoprotein abnormalities in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Recommendation for strict control of plasma triglyceride in diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Long-term treatment of hypercholesterolemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride

1 reference

https://api.crossref.org/works/10.1016%2FS0950-351X%2805%2980078-3

7 January 2021

10.1016/S0950-351X(05)80078-3

Identifiers

DOI

1 reference

23 August 2017

1 reference